Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol Reconsolidation Blockade for PTSD
NCT04982211Phase 2Unknown
- Sponsor
- Douglas Mental Health University Institute
- Start
- Aug 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of propranolol in post-traumatic stress disorder (PTSD) (4 arms), sponsored by Douglas Mental Health University Institute. Primary endpoint: Post-traumatic Checklist for DSM-5. Status: unknown.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04982211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04982211.